Abstract
Tumour-derived factors suppress differentiation and function of in vitro generated DC. Here, we investigate the effect of two melanoma clones differing in their invasive and metastatic properties on the generation and/or functional maturation of human epidermal LC. LC were generated from CD34+ cord blood progenitors under GM-CSF/TNF-α/TGF-β1. CD34+ cells were co-cultured with or without melanoma cells using Transwell dishes. After 11 days of co-culture, CD34+-derived cells display a non-adherent undifferentiated morphology, a high level of monocytic CD14 marker, a down-regulated expression of LC markers (CD1a, E-cadherin) and DC markers (CD40, CD80, CD54, CD58, CD83, CD86, HLA-DR, HLA-class I). These cells were less potent than control LC in inducing allogeneic T cell proliferation. The generation of the CD14+ population was correlated with a decrease in the CD1a+ population, without any statistical differences between the two clones. Melanoma cells diverted the differentiation of CD34+ cells towards a dominant CD14+ population only if the progenitors were in an early growth phase. IL-10, TGF-β1 and VEGF were not responsible for these effects, as assessed by using blocking antibodies. By contrast, co-culture of fresh epidermal LC with melanoma cells did not affect their phenotype and function. Our data demonstrate that melanoma cells inhibit the earliest steps of LC differentiation, but failed to affect the functional maturation of epidermal LC. This suggests that melanoma cells participate in their own escape from immunosurveillance by preventing LC generation in the local cutaneous microenvironment. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252
Béchetoille N, Haftek M, Staquet MJ, Cochran AJ, Schmitt D and Berthier-Vergnes O (2000) Penetration of human metastatic melanoma cells through an authentic dermal–epidermal junction is associated with dissolution of native collagen types IV and VII. Melanoma Res 10: 427–434
Berthier-Vergnes O, Zebda N, Bailly M, Bailly C, Doré JF, Thomas L and Cochran AJ (1993) Expression of peanut agglutinin-binding glycoconjugates in primary melanomas with high risk of metastases. Lancet 341: 1292
Caux C, Dezutter-Dambuyant C, Schmitt D and Banchereau J (1992) GM-CSF and TNF α cooperate in generation of dendritic Langerhans cells. Nature 360: 258–261
Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu YJ and Banchereau J (1994) Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 8: 1177–1185
Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C and Yoneda K et al (1996) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic pathways in response to GM-CSF+TNFα. J Exp Med 184: 695–706
Caux C, Massacrier C, Dubois B, Valladeau J, Dezutter-Dambuyant C, Durand I and Schmitt D et al (1999) Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J Leukoc Biol 66: 781–791
Enk AH, Jonuleit H, Saloga J and Knop J (1997) Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73: 309–316
Esche C, Lokshin A, Shurin GV, Gastman BR, Rabinowich H, Watkins SC, Lotze MT and Shurin MR (1999) Tumor’s other immune targets: dendritic cells. J Leukoc Biol 66: 336–344
Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D and Carbone DP (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2: 1096–1103
Guerrin M, Moukadiri H, Chollet P, Moro F, Dutt K, Malecaze F and Plouët J (1995) Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells. J Cell Physiol 164: 385–394
Hart DNJ (1997) Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245–3287
Ishida T, Oyama T, Carbone DP and Gabrilovich DL (1998) Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. J Immunol 161: 4842–4851
Jaksits S, Kriehuber E, Charbonnier AS, Rappersberger K, Stingl G and Maurer D (1999) CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta-dependent manner. J Immunol 163: 4869–4877
Katsenelson NS, Shurin GV, Bykovskaia SN, Shogan J and Shurin MR (2001) Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function. Mod Pathol 14: 40–45
Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C and Blay JY (1998) Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of Interleukin-6 and macrophage colony-stimulating factor. Blood 92: 4778–4791
Péguet-Navarro J, Moulon C, Caux C, Dalbiez-Gauthier C, Banchereau J and Schmitt D (1994) Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 24: 884–891
Péguet-Navarro J, Dalbiez-Gauthier C, Rattis FM, Van Kooten C, Banchereau J and Schmitt D (1995) Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 155: 4241–4247
Pirtskhalaishvili G, Shurin GV, Esche C, Cai Q, Salup RR, Bykovskaia SN, Lotze MT and Shurin MR (2000) Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 83: 506–513
Reid CD, Stackpoole A, Meager A and Tikerpae J (1992) Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 149: 2681–2688
Riedl E, Strobl H, Majdic O and Knapp W (1997) TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 158: 1591–1597
Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT and Barksdale EM Jr. (2001) Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61: 363–369
Steinbrink K, Wolfl M, Jonuleit H, Knop J and Enk AH (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159: 4772–4780
Stene MA, Babajanians M, Bhuta S and Cochran AJ (1988) Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin. J Invest Dermatol 91: 125–128
Strobl H, Riedl E, Scheinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Madjic O and Knapp W (1996) TGF-β1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 157: 1499–1507
Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E, Elbe A, Maurer D and Stingl G (1996) Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 87: 1292–1302
Toriyama K, Wen DR, Paul E and Cochran AJ (1993) Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin. J Invest Dermatol 100: 269s–273s
Trompezinski S, Pernet I, Mayoux C, Schmitt D and Viac J (2000) Transforming growth factor-betal and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. Br J Dermatol 143: 539–545
Zebda N, Bailly M, Brown S, Doré JF and Berthier-Vergnes O (1994a) Expression of PNA-binding sites on specific glycoproteins by human melanoma cells is associated with a high metastatic potential. J Cell Biochem 54: 161–173
Zebda N, Pedron S, Rebbaa A, Portoukalian J and Berthier-Vergnes O (1994b) Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc: LacCer α2,3 sialyltransférase (GM3 synthase). FEBS Letters 362: 161–164
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Berthier-Vergnes, O., Gaucherand, M., Péguet-Navarro, J. et al. Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells. Br J Cancer 85, 1944–1951 (2001). https://doi.org/10.1054/bjoc.2001.2183
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2183
Keywords
This article is cited by
-
Colorectal Cancer and Tumor Stromal Cells Have Different Effects on the Differentiation and Maturation of Dendritic Cells In Vitro
Bulletin of Experimental Biology and Medicine (2023)
-
Langerhans Cells from Human Cutaneous Squamous Cell Carcinoma Induce Strong Type 1 Immunity
Journal of Investigative Dermatology (2012)
-
Overview of a HLA-Ig based “Lego-like system” for T cell monitoring, modulation and expansion
Immunologic Research (2010)
-
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells
Cancer Immunology, Immunotherapy (2008)
-
Immunotherapy for melanoma: The good, the bad, and the future
Current Oncology Reports (2005)